Toronto Stocks Dip, Organigram Boosts Investment in Phylos Bioscience
ByAinvest
Wednesday, Dec 31, 2025 12:23 pm ET1min read
OGI--
Toronto stocks declined by 0.3% on the final trading day of 2025, with losses in health services, manufacturing, and process industries outweighing gains in the tech, communications, and materials sectors. Organigram Global increased its investment in cannabis genetics company Phylos Bioscience by $3 million, giving it priority access to cannabis plant seeds. The TSX will be closed on January 1 for New Year's Day and reopen on Friday.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet